View in EDS

The Parkinson's disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release.

Saved in:
Bibliographic Details
Title: The Parkinson's disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release.
Authors: Apicco DJ; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142; dan.apicco@gmail.com warren.hirst@biogen.com.; Biogen Postdoctoral Scientist Program, Biogen, Cambridge, MA 02142., Shlevkov E; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Nezich CL; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Tran DT; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Guilmette E; Gene Therapy Accelerator Unit, Biotherapeutics and Medicinal Sciences, Biogen, Cambridge, MA 02142., Nicholatos JW; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142.; Biogen Postdoctoral Scientist Program, Biogen, Cambridge, MA 02142., Bantle CM; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142.; Biogen Postdoctoral Scientist Program, Biogen, Cambridge, MA 02142., Chen Y; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Glajch KE; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Abraham NA; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Dang LT; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Kaynor GC; Multiple Sclerosis and Neurorepair Research Unit, Biogen, Cambridge, MA 02142., Tsai EA; Human Genetics, Translational Biology, Biogen, Cambridge, MA 02142., Nguyen KH; Human Genetics, Translational Biology, Biogen, Cambridge, MA 02142., Groot J; Genome Technologies and Scientific Computing, Translational Biology, Biogen, Cambridge, MA 02142., Liu Y; Biologics Drug Discovery, Biotherapeutics and Medicinal Sciences, Biogen, Cambridge, MA 02142., Weihofen A; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Hurt JA; Human Target Validation Core, Translational Biology, Biogen, Cambridge, MA 02142., Runz H; Human Genetics, Translational Biology, Biogen, Cambridge, MA 02142., Hirst WD; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142; dan.apicco@gmail.com warren.hirst@biogen.com.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Jan 05; Vol. 118 (1).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.2006476118